Structure–activity relationship models for rat carcinogenesis and assessing the role mutagens play in model predictivity

References

• US EPA, TSCA Inventory Reset (2010). Available at http://www.epa.gov/champ/pubs/hpv/tsca.html [accessed 11 November 2013].
   Google Scholar
• R. Judson, A. Richard, D.J. Dix, K. Houck, M. Martin, R. Kavlock, V. Dellarco, T. Henry, T. Holderman, P. Sayre, S. Tan, T. Carpenter, and E. Smith, The toxicity data landscape for environmental chemicals, Environ. Health Perspect. 117 (2009), pp. 685–695.
   PubMed Web of Science ®Google Scholar
• J. Huff, Long-term chemical carcinogenesis bioassays predict human cancer hazards. Issues, controversies, and uncertainties, Ann. N.Y. Acad. Sci. 895 (1999), pp. 56–79.
   PubMed Web of Science ®Google Scholar
• European Parliament and Council, Regulation (EC) No 1907/2006 of the European Parliament and of the Council, Off. J. Eur. Union L396 (2007), pp. 1–851.
   Google Scholar
• E.S. Williams, J. Panko, and D.J. Paustenbach, The European Union’s REACH regulation: A review of its history and requirements, Crit. Rev. Toxicol. 39 (2009), pp. 553–575.
   PubMed Web of Science ®Google Scholar
• B.F. Koop, Human and rodent DNA sequence comparisons: A mosaic model of genomic evolution, Trends Genet. 11 (1995), pp. 367–371.
   PubMed Web of Science ®Google Scholar
• J. Huff, Animal and human carcinogens, Environ. Health Perspect. 107 (1999), pp. A341–A342.
   PubMed Web of Science ®Google Scholar
• B.N. Ames and L.S. Gold, Chemical carcinogenesis: Too many rodent carcinogens, Proc. Natl. Acad. Sci. U. S. A 87 (1990), pp. 7772–7776.
   PubMed Web of Science ®Google Scholar
• J. Ashby, International commission for protection against environmental mutagens and carcinogens. two million rodent carcinogens? The role of SAR and QSAR in their detection, Mutat. Res. 305 (1994), pp. 3–12.
   PubMed Web of Science ®Google Scholar
• D. Krewski, M.E. Andersen, E. Mantus, and L. Zeise, Toxicity testing in the 21st century: Implications for human health risk assessment, Risk Anal. 29 (2009), pp. 474–479.
   PubMed Web of Science ®Google Scholar
• R. Benigni and C. Bossa, Predictivity of QSAR, J. Chem. Inf. Model. 48 (2008), pp. 971–980.
   PubMed Web of Science ®Google Scholar
• R. Benigni and C. Bossa, Predictivity and reliability of QSAR models: The case of mutagens and carcinogens, Toxicol. Mech. Meth. 18 (2008), pp. 137–147.
   PubMed Web of Science ®Google Scholar
• J.D. McKinney, A. Richard, C. Waller, M.C. Newman, and F. Gerberick, The practice of structure activity relationships (SAR) in toxicology, Toxicol. Sci. 56 (2000), pp. 8–17.
   PubMed Web of Science ®Google Scholar
• H.S. Rosenkranz and G. Klopman, Mutagens, carcinogens, and computers, Prog. Clin. Biol. Res. 209A (1986), pp. 71–104.
   PubMedGoogle Scholar
• H.S. Rosenkranz and G. Klopman, Structural basis of carcinogenicity in rodents of genotoxicants and non-genotoxicants, Mutat. Res. 228 (1990), pp. 105–124.
   PubMed Web of Science ®Google Scholar
• B.W. Blake, K. Enslein, V.K. Gombar, and H.H. Borgstedt, Salmonella mutagenicity and rodent carcinogenicity: Quantitative structure-activity relationships, Mutat. Res. 241 (1990), pp. 261–271.
   PubMed Web of Science ®Google Scholar
• C.A. Marchant, Prediction of rodent carcinogenicity using the DEREK system for 30 chemicals currently being tested by the National Toxicology Program. The DEREK Collaborative Group, Environ. Health Perspect. 104 Suppl. 5, (1996), pp. 1065–1073.
   PubMedGoogle Scholar
• J. Ashby, Fundamental structural alerts to potential carcinogenicity or noncarcinogenicity, Environ. Mutagen. 7 (1985), pp. 919–921.
   PubMedGoogle Scholar
• J. Ashby and D. Paton, The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures, Mutat. Res. 286 (1993), pp. 3–74.
   PubMed Web of Science ®Google Scholar
• J. Ashby and R.W. Tennant, Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP, Mutat. Res. 204 (1988), pp. 17–115.
   PubMed Web of Science ®Google Scholar
• H. Zhu, I. Rusyn, A. Richard, and A. Tropsha, Use of cell viability assay data improves the prediction accuracy of conventional quantitative structure-activity relationship models of animal carcinogenicity, Environ. Health Perspect. 116 (2008), pp. 506–513.
   PubMed Web of Science ®Google Scholar
• R. Benigni and R. Zito, The second National Toxicology Program comparative exercise on the prediction of rodent carcinogenicity: Definitive results, Mutat. Res. 566 (2004), pp. 49–63.
   PubMed Web of Science ®Google Scholar
• L.G. Valerio. Jr., In silico toxicology for the pharmaceutical sciences, Toxicol. Appl. Pharmacol. 241 (2009), pp. 356–370.
   PubMed Web of Science ®Google Scholar
• M. Zeeman, C.M. Auer, R.G. Clements, J.V. Nabholz, and R.S. Boethling, U.S. EPA regulatory perspectives on the use of QSAR for new and existing chemical evaluations, SAR QSAR Environ. Res. 3 (1995), pp. 179–201.
   PubMedGoogle Scholar
• U.S. EPA, OncoLogic™ – A Computer System to Evaluate the Carcinogenic Potential of Chemicals (2013). Available at http://www.epa.gov/oppt/sf/pubs/oncologic.htm [accessed 11 November 2013].
   Google Scholar
• A.R. Cunningham, G. Klopman, and H.S. Rosenkranz, Identification of structural features and associated mechanisms of action for carcinogens in rats, Mutat. Res. 405 (1998), pp. 9–27.
   PubMed Web of Science ®Google Scholar
• L.S. Gold, V.M. de Veciana, G.M. Backman, R. Magaw, P. Lopipero, M. Smith, M. Blumenthal, R. Levinson, L. Bernstein, and B.N. Ames, Chronological supplement to the Carcinogenic Potency Database: Standardized Results of animal bioassays published through December 1982, Environ. Health Perspect. 67 (1986), pp. 161–200.
   Google Scholar
• L.S. Gold, N.B. Manley, T.H. Slone, G.B. Garfinkel, L. Rohrbach, and B.N. Ames, The fifth plot of the Carcinogenic Potency Database: Results of animal bioassays published in the general literature through and by the National Toxicology Program through 1989, Environ. Health Perspect. 100(1993), pp. 65–168.
   Google Scholar
• L.S. Gold, N.B. Manley, T.H. Slone, and L. Rohrbach, Supplement to the Carcinogenic Potency Database (CPDB): Results of animal bioassays published in the general literature in 1993 to 1994 and by the National Toxicology Program in 1995 to 1996, Environ. Health Perspect. 107 Suppl. 4 (1999), pp. 527–600.
   PubMed Web of Science ®Google Scholar
• L.S. Gold, N. Manley, T. Slone, L. Rohrbach, and G. Garfinkel, Supplement to the Carcinogenic Potency Database (CPDB): Results of animal bioassays published in the general literature through 1997, and by the National Toxicology Program in 1997–1998, Toxicol. Sci. 85 (2005), pp. 747–808.
   Google Scholar
• L.S. Gold, C. Sawyer, R. Magaw, G. Backman, V.M. de Veciana, R. Levinson, N.K. Hooper, W.R. Havender, L. Bernstein, and R. Peto, A carcinogenic potency database of the standardized results of animal bioassays, Environ. Health Perspect. 58 (1984), pp. 9–319.
   PubMed Web of Science ®Google Scholar
• L.S. Gold, T.H. Slone, G.M. Backman, S. Eisenberg, C.M. Da, M. Wong, N.B. Manley, L. Rohrbach, and B.N. Ames, Third chronological supplement to the carcinogenic potency database: Standardized results of animal bioassays published through December 1986, and by the National Toxicology Program through June 1987, Environ. Health Perspect. 84 (1990), pp. 215–286.
   Google Scholar
• L.S. Gold, T.H. Slone, G.M. Backman, R. Magaw, C.M. Da, P. Lopipero, M. Blumenthal, and B.N. Ames, Second chronological supplement to the Carcinogenic Potency Database: Standardized results of animal bioassays published through December 1984, and by the National Toxicology Program through May 1986, Environ. Health Perspect. 74 (1987), pp. 237–329.
   Google Scholar
• A.R. Cunningham, C.A. Carrasquer, and D.R. Mattison, A categorical structure-activity relationship analysis of the developmental toxicity of antithyroid drugs, Int. J. Pediatr. Endocrinol. 2009 (2009), p.936154.
   PubMedGoogle Scholar
• A.R. Cunningham, S.L. Cunningham, D.M. Consoer, S.T. Moss, and M.H. Karol, Development of an information-intensive structure-activity relationship model and its application to human respiratory chemical sensitizers, SAR QSAR Environ. Res. 16 (2005), pp. 273–285.
   PubMed Web of Science ®Google Scholar
• A.R. Cunningham, S.T. Moss, S.A. Iype, G. Qian, S. Qamar, and S.L. Cunningham, Structure-activity relationship analysis of rat mammary carcinogens, Chem. Res. Toxicol. 21 (2008), pp. 1970–1982.
   PubMed Web of Science ®Google Scholar
• DSSTox, Distributed Structure-Searchable Toxicity (DSSTox) Database Network: CPDBAS: Carcinogenic Potency Database Summary Tables – All Species Database File, version 5d, (2008). Available at http://www.epa.gov/ncct/dsstox/sdf_cpdbas.html [accessed 11 November 2013].
   Google Scholar
• E. Zeiger, Historical perspective on the development of the genetic toxicity test battery in the United States, Environ. Mol. Mutag. 51 (2010), pp. 781–791.
   PubMed Web of Science ®Google Scholar
• R.D. Combes, The use of structure-activity relationships and markers of cell toxicity to detect non-genotoxic carcinogens, Toxicol. In Vitro 14 (2000), pp. 387–399.
   PubMed Web of Science ®Google Scholar
• R. Benigni, C. Bossa, O. Tcheremenskaia, and A. Giuliani, Alternatives to the carcinogenicity bioassay: In silico methods, and the in vitro and in vivo mutagenicity assays, Expert Opin. Drug Metab. Toxicol. 6 (2010), pp. 1–11.
   PubMed Web of Science ®Google Scholar
• Y.T. Woo, Mechanisms of action of chemical carcinogens, and their role in structure–activity relationship (SAR) analysis and risk assessment, in Quantitative Structure-Activity Relationship (QSAR) Models of Mutagens and Carcinogens, R. Benigni, ed., CRC Press, Boca Raton, FL, 2013, pp. 41–80.
   Google Scholar
• A.R. Cunningham, C.A. Carrasquer, S. Qamar, J.M. Maguire, S.L. Cunningham, and J.O. Trent, Global structure-activity relationship model for nonmutagenic carcinogens using virtual ligand-protein interactions as model descriptors, Carcinogenesis 33 (2012), pp. 1940–1945.
   PubMed Web of Science ®Google Scholar
• L.S. Gold, T.H. Slone, and B.N. Ames, Overview and update of analyses of the Carcinogenic Potency Database, in Handbook of Carcinogenic Potency and Genotoxicity Databases, L.S. Gold and E. Zeiger, eds., CRC Press, New York, 1997, pp. 661–693.
   Google Scholar
• A.R. Cunningham, H.S. Rosenkranz, Y.P. Zhang, and G. Klopman, Identification of ‘genotoxic’ and ‘non-genotoxic’ alerts for cancer in mice: The carcinogenic potency database, Mutat. Res. 398 (1998), pp. 1–17.
   PubMed Web of Science ®Google Scholar
• I.C. Shaw and H.B. Jones, Mechanisms of non-genotoxic carcinogenesis, Trends Pharmacol. Sci. 15, (1994), pp. 89–93.
   PubMed Web of Science ®Google Scholar
• H. Yamasaki, Non-genotoxic mechanisms of carcinogenesis: Studies of cell transformation and gap junctional intercellular communication, Toxicol. Lett. 77 (1995), pp. 55–61.
   PubMed Web of Science ®Google Scholar
• L. Verna, J. Whysner, and G.M. Williams, 2-Acetylaminofluorene mechanistic data and risk assessment: DNA reactivity, enhanced cell proliferation and tumor initiation, Pharmacol. Ther. 71 (1996), pp. 83–105.
   PubMed Web of Science ®Google Scholar
• H.H. Kuo, S.S. Shyu, and T.C. Wang, Genotoxicity of low dose N-nitroso propoxur to human gastric cells, Food Chem. Toxicol. 46 (2008), pp. 1619–1626.
   PubMed Web of Science ®Google Scholar
• T.C. Wang, J.M. Chiou, Y.L. Chang, and M.C. Hu, Genotoxicity of propoxur and its N-nitroso derivative in mammalian cells, Carcinogenesis 19 (1998), pp. 623–629.
   PubMed Web of Science ®Google Scholar
• K. Hemminki, Reactions of beta-propiolactone, beta-butyrolactone and gamma-butyrolactone with nucleic acids, Chem. Biol. Interac. 34 (1981), pp. 323–331.
   PubMed Web of Science ®Google Scholar